Symposium on molecular radiotherapy dosimetry: The first of a series?

Manuel Bardiès,Pablo Minguez Gabiña,Glenn Flux,Pola Platoni,Efi Koutsouveli

DOI: https://doi.org/10.1016/j.ejmp.2024.103328

IF: 3.119

2024-03-19

Physica Medica

Abstract:Highlights • The first Symposium on Molecular Radiotherapy Dosimetry: the future of theragnostic was organised in Athens in Nov 2023. • Initially planned for 110 attendees, an larger facility had to be found to welcome 180 participants. • Several abstracts (80) were submitted, and 48 accepted as oral, 30 as electronic posters. • Eight sessions were organised (with invited speakers and oral presentations), 3 ePoster sessions, a specific sponsor session, 2 CPD sessions and a round table associating physicists, physicians, patient representatives took place during that very busy meeting. • A specific session was organised to present the newly published EFOMP Policy Statement 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy. • The event was considered a great success and is likely to become the first of a series. The EFOMP Special Interest Group for Radionuclide Internal Dosimetry (SIG_FRID) organised its first scientific meeting, the Symposium on Molecular Radiotherapy Dosimetry, in Athens on November 9th–11th 2023. The Symposium was hosted by the Hellenic Association of Medical Physicists and the National and Kapodistrian University of Athens. This meeting gathered more than 180 scientists from 28 countries. Scientific, clinical and regulatory aspects were addressed by 8 invited experts. Two continuous professional development sessions were organised. A special round table gathering medical physics experts, physicians regulatory authority experts and patient representatives addressed the possibilities to increase clinical dosimetry dissemination. The event was supported by companies and a specific industry session allowed sponsors to present their products, innovations and future perspective in this field.

radiology, nuclear medicine & medical imaging